Not all sufferers with CLL involve therapy. In spite of all new advances, the iwCLL nevertheless suggests watchful observation for people with asymptomatic illness.86 This advice is predicated on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari masyarakat https://horacel319emt5.theisblog.com/profile